Despite continued market positivity about AI in the pharmaceutical industry, Absci's latest earnings report had the majority of its analysts dropping their price targets by almost 10%.

UBER has had strong revenue and free cash flow (FCF) growth. Its FCF margins are approaching 20%. That could push UBER stock up 27% based on its trailing 12-month FCF yield metric, or $119.00 per share.